Volume 19, Number 3—March 2013
Synopsis
Human Leptospirosis Trends, the Netherlands, 1925–2008
Marga G.A. Goris
, Kimberly R. Boer, Tamara A.T.E. Duarte, Suzanne J. Kliffen, and Rudy A. Hartskeerl
, Kimberly R. Boer, Tamara A.T.E. Duarte, Suzanne J. Kliffen, and Rudy A. HartskeerlTable 3
Treatment course and deaths, by infecting Leptospira spp. serogroups, for case-patients with leptospirosis, the Netherlands, 1925–2008*
| Serogroup | No. patients | No. (%) hospitalized | No. (%) treated with dialysis | No. (%) treated in ICU | No (%) died |
|---|---|---|---|---|---|
| Icterohaemorrhagiae | 1,702 | 1,311 (77.0) | 90 (11.9) | 68 (7.0) | 90 (5.3) |
| Grippotyphosa | 196 | 124 (63.3) | 3 (2.2) | 2 (1.2) | 0 |
| Sejroe | 128 | 48 (37.5) | 3 (2.4) | 2 (1.6) | 1 (0.8) |
| Canicola | 93 | 60 (64.5) | 0 | 0 (0.0) | 3 (3.2) |
| Pomona | 54 | 40 (74.1) | 3 (5.6) | 7 (13.0) | 0 |
| Other | 81 | 55 (67.9) | 3 (3.8) | 6 (7.6) | 1 (1.9) |
| Unknown | 299 | 213 (71.2) | 17 (8.6) | 21 (9.3) | 71 (23.7) |
*ICU, intensive care unit. Data were available for 2,553 patients who were hospitalized or died, 1,360 patients treated with dialysis, and 1,641 patients treated in an ICU.
